Koo Hee Sang, Kang Sung Don, Lee Ju Hwan, Kim Nam-Ho, Chung Hun-Taeg, Pae Hyun-Ock
Department of Neurosurgery, Wonkwang University School of Medicine, Iksan, Korea.
J Korean Neurosurg Soc. 2009 Oct;46(4):389-96. doi: 10.3340/jkns.2009.46.4.389. Epub 2009 Oct 31.
Triptolide (TP) has been reported to suppress the expression of mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), of which main function is to inactivate the extracellular signal-regulated kinase-1/2 (ERK-1/2), the p38 MAPK and the c-Jun N-terminal kinase-1/2 (JNK-1/2), and to exert antiproliferative and pro-apoptotic activities. However, the mechanisms underlying antiproliferative and pro-apoptotic activities of TP are not fully understood. The purpose of this study was to examine whether the down-regulation of MKP-1 expression by TP would account for antiproliferative activity of TP in immortalized HT22 hippocampal cells.
MKP-1 expression and MAPK phosphorylation were analyzed by Western blot. Cell proliferation was assessed by (3)H-thymidine incorporation. Small interfering RNA (siRNA) against MKP-1, vanadate (a phosphatase inhibitor), U0126 (a specific inhibitor for ERK-1/2), SB203580 (a specific inhibitor for p38 MAPK), and SP600125 (a specific inhibitor for JNK-1/2) were employed to evaluate a possible mechanism of antiproliferative action of TP.
At its non-cytotoxic dose, TP suppressed MKP-1 expression, reduced cell growth, and induced persistent ERK-1/2 activation. Similar growth inhibition and ERK-1/2 activation were observed when MKP-1 expression was blocked by MKP-1 siRNA and its activity was inhibited by vanadate. The antiproliferative effects of TP, MKP-1 siRNA, and vanadate were significantly abolished by U0126, but not by SB203580 or SP600125.
Our findings suggest that TP inhibits the growth of immortalized HT22 hippocampal cells via persistent ERK-1/2 activation by suppressing MKP-1 expression. Additionally, this study provides evidence supporting that MKP-1 may play an important role in regulation of neuronal cell growth.
雷公藤甲素(TP)已被报道可抑制丝裂原活化蛋白激酶(MAPK)磷酸酶-1(MKP-1)的表达,其主要功能是使细胞外信号调节激酶-1/2(ERK-1/2)、p38 MAPK和c-Jun氨基末端激酶-1/2(JNK-1/2)失活,并发挥抗增殖和促凋亡活性。然而,TP抗增殖和促凋亡活性的潜在机制尚未完全阐明。本研究的目的是探讨TP下调MKP-1表达是否可解释其在永生化HT22海马细胞中的抗增殖活性。
通过蛋白质免疫印迹法分析MKP-1表达和MAPK磷酸化。通过³H-胸腺嘧啶核苷掺入评估细胞增殖。使用针对MKP-1的小干扰RNA(siRNA)、钒酸盐(一种磷酸酶抑制剂)、U0126(ERK-1/2的特异性抑制剂)、SB203580(p38 MAPK的特异性抑制剂)和SP600125(JNK-1/2的特异性抑制剂)来评估TP抗增殖作用的可能机制。
在其非细胞毒性剂量下,TP抑制MKP-1表达,减少细胞生长,并诱导ERK-1/2持续激活。当MKP-1表达被MKP-1 siRNA阻断且其活性被钒酸盐抑制时,观察到类似的生长抑制和ERK-1/2激活。U0126可显著消除TP、MKP-1 siRNA和钒酸盐的抗增殖作用,但SB203580或SP600125则不能。
我们的研究结果表明,TP通过抑制MKP-1表达使ERK-1/2持续激活,从而抑制永生化HT22海马细胞的生长。此外,本研究提供了证据支持MKP-1可能在神经元细胞生长调节中起重要作用。